Comparison of Ga-68 PSMA PET/CT and Multiparametric MRI for Initial Detection and Staging of Prostate Cancer
World Journal of Nuclear Medicine · 01.06.2024 · 23 (02) · 079-087
DOI: 10.1055/s-0044-1779749 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Nuclear Medicine, erschienen am 01.06.2024. Verfasst von Dinesh Kumar Gauthaman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and PET/CT, Jaslok Hospital, Mumbai, Maharashtra, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Multiparametric magnetic resonance imaging (mpMRI) is widely used for the evaluation of prostate cancer and is known to have better accuracy. Gallium-68 prostate-specific membrane antigen (Ga-68 PSMA) is a radiotracer that shows high localization in prostate cancer cells.
Purpose
The purpose of this study was to assess the sensitivity and utility of Ga-68 PSMA positron emission tomography/computed tomography (PET/CT) in comparison with mpMRI as a noninvasive imaging technique for the initial diagnosis and locoregional staging of prostate cancer using transrectal ultrasound (TRUS)-guided biopsy as gold standard. Materials and Methods This prospective observational study conducted from August 2017 to April 2020 evaluated 60 men (n = 60) with biopsy-proven prostate carcinoma. They underwent mpMRI and Ga-68 PSMA PET/CT scans within 14 days with TRUS biopsy being gold standard. T staging of disease, N staging of lymph nodes within the pelvis, and M staging of lesions in pelvic bones (within the imaging field of mpMRI) were compared using PSPP version 1.0.1 statistical software.
Results
All 60 men with a mean age of 69.9 ± 9.35 years showed Ga-68 PSMA avid disease, whereas 55 were detected by mpMRI. The sensitivity in detection of prostate lesions (with 95% confidence interval) was 99.08% for Ga-68 PSMA PET/CT and 84.40% for mpMRI. Ga-68 PSMA PET/CT detected greater number of patients with regional lymph nodal involvement (19/60) as compared with mpMRI (12/60). Ga-68 PSMA PET/CT showed PSMA avid pelvic skeletal lesions in nine patients, whereas mpMRI detected pelvic lesions in six patients. In addition, four other patients showed extrapelvic skeletal lesions on Ga-68 PSMA PET/CT.
Conclusion
Ga-68 PSMA PET/CT has superior sensitivity in detection of primary prostate tumor, as compared with mpMRI. Both modalities correlate well in detection of seminal vesicle involvement. Ga-68 PSMA PET/CT outperformed mpMRI in detection of lymph nodal and skeletal metastases. Hence, Ga-68 PSMA PET/CT should be considered as first-line diagnostic modality for carcinoma prostate. Summary Statement: Ga-68 PSMA PET/CT shows superior diagnostic performance than mpMRI in the evaluation of prostate cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine and PET/CT, Jaslok Hospital, Mumbai, Maharashtra, India.
Zitieren
APA
Gauthaman, D. K., Luthra, K., & Lele, V. (2024). Comparison of Ga-68 PSMA PET/CT and Multiparametric MRI for Initial Detection and Staging of Prostate Cancer. World Journal of Nuclear Medicine, 23(02), 079-087. https://doi.org/10.1055/s-0044-1779749
Vancouver
Gauthaman DK, Luthra K, Lele V. Comparison of Ga-68 PSMA PET/CT and Multiparametric MRI for Initial Detection and Staging of Prostate Cancer. World Journal of Nuclear Medicine. 2024;23(02):079-087. doi:10.1055/s-0044-1779749
BibTeX
@article{Gauthaman2024,
author = {Gauthaman, Dinesh Kumar and Luthra, Karuna and Lele, Vikram},
title = {Comparison of Ga-68 PSMA PET/CT and Multiparametric MRI for Initial Detection and Staging of Prostate Cancer},
journal = {World Journal of Nuclear Medicine},
year = {2024},
volume = {23},
number = {02},
pages = {079--087},
doi = {10.1055/s-0044-1779749}
}
EUVIMED